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1. Introduction 
Acute post-streptococcal glomerulonephritis (APSGN) is one of the nonsuppurative 
sequelae that can occur following a group A streptococcal infection, the other common post-
infection sequelae being rheumatic heart disease. Worldwide, it is estimated that 
approximately 470,000 cases of APSGN occur annually. Children and young adults most 
commonly are affected with males having twice the incidence as females.  By the middle of 
the twentieth century, evidence was found that streptococcal skin infections were associated 
with APSGN, and these infections usually did not cause rheumatic fever, leading to the 
hypothesis that certain GAS strains were “rheumatogenic” while others were 
“nephritogenic.”  In contrast to the molecular and immunological details that have brought 
considerable insight into the pathogenesis of rheumatic heart disease, the bacterial and host 
factors that contribute to ASPGN remain poorly defined and at times controversial.  Modern 
bacterial genome sequencing projects have now provided a rich genetic resource that 
includes complete sequences of nephritogenic group A streptococcus strain NZ131 (McShan 
et al., 2008) and nephritogenic group C streptococcus strain MGCS10565 (Beres et al., 2008) 
as well as other group A and C strains associated with rheumatic heart disease and other 
syndromes.  A metagenomic analysis is presented and considers the contribution of genes 
previously associated with APSGN strains (such as streptokinase, protease SpeB, and M 
protein) as well as other potential genetic factors that may be found uniquely in these 
genomes including genes acquired by horizontal transfer and via mobile genetic elements.  
This analysis provides complementary information to the many published studies using 
nephritogenic S. pyogenes strain NZ131 and places them in a broader context, shedding light 
upon the genetic basis for the human disease caused by this and related streptococci. 
2. Acute post-streptococcal glomerulonephritis 
Streptococcus pyogenes (group A streptococcus) is a common bacterial pathogen of humans, 
causing a wide range of disease from uncomplicated pharyngitis to severe life-threatening 
infections like toxic shock syndrome or necrotizing fasciitis.  Acute post-streptococcal 
glomerulonephritis (APSGN) is one of the two major post-infection sequelae that can follow 
acute streptococcal infections, the other being rheumatic heart disease.  The typical causative 
agent of APSGN is the group A streptococcus although other Lancefield groups may 
occasionally trigger this disease.  Worldwide, it is estimated that approximately 470,000 
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cases of APSGN occur annually (Carapetis et al., 2005).  Children and young adults are the 
group that is most commonly presents with APSGN, and males have twice the incidence as 
females (Silva, 1998).   
The link between group A streptococcal infections and the onset of nephritis was considered 
as early as 1917 by Ophuls (Ophuls, 1917).  By the 1940s, a link had been found between 
streptococcal skin infections and the onset of APSGN, and since the associated strains usually 
did not cause rheumatic fever, the hypothesis was developed that certain S. pyogenes strains 
were “rheumatogenic” while others were “nephritogenic” (Futcher, 1940; Osman et al., 1933; 
Seegal and Earle, 1941).  Additionally, it was observed that there were divergent seasonal 
patterns of peak incidence separating nephritogenic and rheumatogenic GAS, with skin 
infections and APSGN cases peaking in the late summer while throat infections and rheumatic 
fever had the highest incidence in October (Bisno et al., 1970).  Cases of rheumatic fever were 
rare during the summer APSGN outbreaks, peaking instead during the autumn season.  These 
observations lead to the development of the hypothesis that subpopulations of GAS exist that 
were adapted for colonization and infection of either the throat or the skin.  These “throat 
specialists” and “skin specialists” were proposed to have specific sets of virulence factors that 
lead to the post-streptococcal sequelae of rheumatic heart disease or APSGN, respectively.  
This hypothesis has been refined over time to now define throat specialists, skin specialists and 
generalists using a classification scheme that relates the Mga regulon, the gene complement 
surrounding the major antiphagocytic protein M gene (emm), to preferred anatomical site of 
infection (Bessen et al., 1997; Enright et al., 2001; McGregor et al., 2004).   
3. Comparative genomics of nephritogenic streptococcal strains 
3.1 The nephritogenic streptococcal genomes 
The role of streptococcal induced autoimmunity as the basis for the development of rheumatic 
heart disease has been supported by a number of detailed studies (Cunningham, 2000a; 
Cunningham et al., 1989; Ellis et al., 2010; Krisher and Cunningham, 1985).  It is reasonable 
therefore to expect that a similar underlying source of antigenic cross-reactivity might be 
responsible for the development of APSGN, especially since the time of onset roughly follows 
the time required for the adaptive immune response.  However, to date no definitive link has 
been found although a number of candidate streptococcal proteins have been proposed over 
the years, including streptokinase, protease SpeB, and the antiphagocytic M protein (reviewed 
by Cunningham (Cunningham, 2000b)).  One of the goal’s for genome sequencing of multiple 
streptococcal strains associated with different diseases was to use comparative genomics to 
gain insight into the genetic variations that underlie virulence.  Several nephritogenic 
streptococcal isolates now have had their genome sequences determined, and this information 
will be crucial in understanding the pathogenic mechanisms underlying APSGN.   
3.2 Physical chromosome characteristics 
The genomes of nephritis-associated streptococcal isolates S. pyogenes NZ131 (group A) and S. 
equi subsp. zooepidemicus MGCS10565 (group C) were completely sequenced in independent 
efforts in 2008 (Beres et al., 2008; McShan et al., 2008).  Both of these isolates were originally 
isolated from cases of human glomerulonephritis (Beres et al., 2008; McShan et al., 2008); 
additionally, NZ131 has been also studied intensively in over thirty published studies 
(McShan et al., 2008).  Both genomes are single circular molecules of 1,815,783 bp and 2,024,171 
bp for NZ131 and MGCS10565, respectively.  Neither strain has been found to have naturally 
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occurring plasmids or other episomes.  Strain NZ131 has 1,699 predicted open reading frames 
(ORFs) that use 1,548,919 bases so that 85.3% of the genomic DNA is used as coding sequences.  
The base composition of the ORFs is 39.18% G+C while the composition of the total genome is 
38.57%; both values are similar to the composition seen in the other completed GAS genomes 
(McShan et al., 2008). The MGCS10565 genome has a 42.59% G+C content, and its genome has 
1,961 predicted ORFs, which require 85% of the genome (Beres et al., 2008).  The physical 
parameters of both genomes are typical for the family streptococcaceae.   
3.3 Prophages and mobile genetic elements 
Strikingly, strain NZ131 carries three prophages in its genome while MGCS10565 carries none.  
Prophages are always prominent features in the group A streptococcal genomes, sometimes 
accounting for 10% of the total DNA, and are well-known as vectors for carrying virulence 
genes such as superantigens or other bioactive proteins.  While MGCS10565 has genes that are 
homologous to prophage integrases or regulatory proteins as well as virulence factors that are 
often associated with prophages (two DNases and a phospholipase A2), no organized 
prophage genome exists (Beres et al., 2008).  This lack of prophages is in contrast to the S. equi 
subsp. zooepidemicus animal pathogen strain NC_012470 that was recently described as having 
four endogenous prophages (Holden et al., 2009).   
The naturally competent streptococci have the comCDE operon that is thought to be 
essential in genetic transformation (Cvitkovitch, 2001).  Although a previous study had not 
found this operon in S. equi subsp. zooepidemicus strain NCTC 4676 (Havarstein et al., 1997), 
it is present in MGSA10565 (Beres et al., 2008).  The genomes of the naturally competent 
streptococci (including S. pneumoniae and S. mutans (Ajdic et al., 2002; Hoskins et al., 2001; 
Tettelin et al., 2001)) contain comCDE and lack prophages, and it is often suggested that 
frequent DNA transformation events may disrupt the genomes of prophages; thus, their 
typical absence.  The presence of comCDE in MGCS10565 suggests that this isolate also may 
be naturally competent for DNA transformation, and this phenotype may be responsible for 
the absence of prophages (Beres et al., 2008).  Balancing that viewpoint is the fact that these 
genes appear in the genome of S. equi subsp. zooepidemicus strain NC_120470, which does 
carry prophages.  Thus, there may be other factors controlling competence in this species. 
The prophages of NZ131 carry the virulence genes streptococcal pyrogenic exotoxin H (speH), 
a streptodornase (spd3) and the paratox gene (McShan et al., 2008). Prophage-associated 
virulence factors have not been linked to APSGN in the literature, and comparison of these 
two genomes would tend to confirm that non-association.  Rather, it would seem that if a 
common genetic trait exists that leads to APSGN, it would be found among the bacterial genes.  
Further, the absence of prophages in MGCS10565 and its potential to be competent suggests 
that if it has acquired genetic material from group A streptococci, it may have occurred via 
uptake of DNA from the environment rather by bacteriophage mediated transduction.  This 
scenario suggests that genetic transfer may be somewhat of a one-way street, flowing from S. 
pyogenes to this and similar S. zooepidemicus strains since group A streptococci have not been 
demonstrated to be naturally competent.  Therefore, the lack of prophages in MGCS10565 
argues that group A streptococci, which probably use transduction as a means for horizontal 
transfer, would be somewhat genetically isolated from these group C streptococcal strains. 
3.4 The nephritogenic strains and diversity 
The NZ131 and MGCS10565 genomes are not collinear with respect to gene order, but a 
great number of genes are shared between the two.  The genome map of NZ131 is shown in 
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Fig. 1 with gene homology comparisons to strains MGCS10565 (circle 6) and MGAS2096 
(circle 5).  Strain MGAS2096 is a group A streptococcus M12 serotype strain that was also 
isolated from a case of APSGN (Beres et al., 2006) and provides an inter-species reference. 
 
 
Fig. 1. The genome map of M49 S. pyogenes strain NZ131.  The NZ131 genome map is 
shown with comparisons to the other two sequenced nephritogenic streptococcal genomes, 
S. pyogenes strain MGAS2096 and S. equi subsp. zooepidemicus strain MGCS10565.  The outer 
circle and circle 4 indicate the positions of the three endogenous prophages in strain NZ131.  
The two circles they enclose (circles 2 and 3) show the location of the predicted NZ131 ORFs 
encoded by the two strands of DNA.  The open reading frames were extracted from S. 
pyogenes strain MGAS2096 and S. equi subsp. zooepidemicus strain MGCS10565 and were 
compared to the genome of NZ131 using tblastx (circles 5 and 6).  Circle 7 shows the specific 
tblastx hits of surface exposed proteins from MGCS10565.  The innermost circles show the 
total G+C percentage of the NZ131 genomic DNA and the %G+C skew.  The ribosomal 
RNA (rRNA) and tRNA (tRNA) genes were not included in the tblastx comparison.  The 
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Overall, the main regions of divergence between the two S. pyogenes strains are in the 
endogenous prophages and other mobile genetic elements (MGE) carried by each (Fig. 1, 
circles 1 and 4), the genetic structures of the M protein gene region (Mga regulon) and 
streptococcal pilus region (circle 5), and by the presence the novel M49 and M82 specific 
NUDIX hydrolase operon in NZ131 (circle 5 (McShan et al., 2008)).  NZ131 prophage 
NZ131.2 shares significant homology with a prophage from MGAS2096 (circle 5) but not 
including the crucial lysogeny module or virulence genes.  Additionally, MGAS2096 has a 
deletion of a cluster of genes required for citrate metabolism (circle 5, about 925 kb on the 
map).  To date, little evidence has been found to suggest that genes found on prophages 
or other MGE play a role in APSGN, and the lack of homology in these elements from the 
two group A streptococcal strains strengthens this idea.  Thus, if a common mechanism 
for triggering APSGN exists, one would predict that bacterially encoded genes would be 
responsible, either in the form of unique nephritis-associated genes or gene alleles.  A 
number of streptococcal proteins have been investigated as potential triggers of APSGN, 
and many of targets remain still largely unexplored.  For example, circles 6 and 7 show 
the homology of MGCS10565 total genes and predicted membrane associated genes, 
respectively, to NZ131.  While the homology is not as complete as was for the inter-
species strain, many genes and particularly genes encoding cell-surface proteins are 
present in this intra-species streptococcus.  Most of these proteins have not had their 
function or their potential immunogenicity identified.  Thus, if genome comparisons tell 
us anything, it is that that many targets for future investigations remain.  However, 
several genes have been considered to play a role in APSGN in previous work, and it is 
worthwhile to examine the variants found in each of these nephritogenic strains for 
possible shared features.   
4. Genes associated with post-streptococcal glomerulonephritis 
4.1 Streptokinase  
Streptokinase is a plasminogen activator that is released as an extracellular protein by 
groups A, C, and G streptococci.  It generates plasmin, which may promote bacterial spread 
through fibrinolysis and degradation of the extracellular matrix as well as induce 
inflammation via complement activation.  This latter event may play a role in post-infection 
sequelae like APSGN (Nordstrand et al., 1999).  It has been proposed that structural 
differences between alleles of streptokinase may be associated with diverse pathogenic 
outcomes, particularly in the variable eta-domain (Lizano and Johnston, 2005).  The role of 
streptokinase in the pathogenesis of APSGN has been supported by the use of a mouse 
model and derivatives of strain NZ131 with either nephritis- or non-nephritis-associated 
alleles of streptokinase (Nordstrand et al., 2000; Nordstrand et al., 1998).   
The streptococcal streptokinase is composed of three domains, which are the highly 
conserved alpha and gamma domains and the variable eta domain (Wang et al., 1998).  The 
alpha and eta domains are associated with plasminogen activation while the variable eta 
domain is not required for this enzymatic activity (Lizano and Johnston, 2005).  However, in 
the mouse model used by Nordstrand and her co-workers, the alleles that caused the onset 
of nephritis mapped their variations to the eta domain (Nordstrand et al., 2000; Nordstrand 
et al., 1998).  These studies, along with clinical observations (Johnston et al., 1992), have lead 
to a proposed role for streptokinase in APSGN, possibly in mediating complement 
deposition in the kidney.   
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One of the striking observations from the genome of the nephritis-associated group C 
MGCS10565 strain is the divergence of the encoded streptokinase when compared to those 
encoded by other group C and group A strains, whether nephritis-associated or not.  Figure 2 
shows a clustalw alignment of the amino acids from the streptokinase eta regions from the 
group A genome strains M1, M2, M3, M4, M6, M12, M18, M28, and M49 as well as the group 
C strains H46 and GGS 124 (S. dysgalactiae subsp. equisimilis) and H70 and MGCS10565 (S. equi 
subsp. zooepidemicus).  The eta region from the two zooepidemicus strains is quite divergent 
from the other streptokinase proteins from both groups A and C subsp. equisimilis strains.  
Considerable divergence is also observed in the alpha and gamma domains (not shown).  The 
eta domain is required for docking to plasminogen via a kringle binding hairpin loop (Dhar 
et al., 2002; Wang et al., 1998), and the variation seen in this region suggests that a number of 
primary sequences are able to generate the needed secondary and tertiary protein structures. 
 
 
Fig. 2. Analysis of the streptokinase gene ska eta-region.  The variable eta-region  
from the ska genes from GAS genome strains (NZ131 (M49, APSGN), MGAS10750 (M4), 
MGAS2096 (M12, APSGN), MGAS6180 (M28), MGAS10270 (M2), SF370 (M1), MGAS315 
(M3), MGAS10394 (M6), and MGAS8232 (M18)) and GCS strains (S. equisimilis H46a,  
S. equisimilis GGS124, MGCS10565 (APSGN), and the non-nephritogenic S. zooepidemicus 
H70) was aligned using CLUSTALW (Thompson et al., 1994) and the resulting consensus 
analyzed using WebLogo (Crooks et al., 2004).  The non-nephritogenic M12 S. pyogenes 
strain MGAS9429 was omitted from this analysis since its sequence is 100% identical  
to that of the nephritis-associated M12 strain MGAS2096. The primary descriptions of 
each of these genomes are found in the literature (Banks et al., 2004; Beres et al., 2006; 
Beres et al., 2008; Beres et al., 2002; Ferretti et al., 2001; Green et al., 2005; Holden et al., 
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Further, it should be noted that a number of conserved neutral amino acid residues are 
positioned in the eta domain, suggesting an essential contribution to function.  Inspection 
of the primary sequence of the streptokinase proteins in this group shows additional 
conserved sequences in the two nephritogenic group A streptococcal isolates (NZ131 and 
MGAS2096) but not found in the nephritogenic group C strain.  Protein folding of this 
domain may create similar structures in both groups that might contribute to APSGN, but 
such information is not available yet.  Interestingly, the streptokinase gene from the non-
nephritis M12 serotype strain MGAS9429 is 100% identical to the nephritogenic M12 strain.  
It is also possible that the mechanisms of pathogenesis that trigger nephritis following 
group A or group C infection may be different.  Clearly, more detailed studies need to be 
done to address the possible role of streptokinase in APSGN. 
4.2 Protease SpeB 
Zabriskie and co-workers first observed that strains were associated with APSGN produced an 
extracellular protein not seen in non-nephritis strains, which was subsequently found to be 
bound to plasmin (Poon-King et al., 1993; Villarreal et al., 1979).  This plasmin binding protein 
was discovered to be the major extracellular protease SpeB, and analysis of patient sera 
showed significantly higher levers of anti-SpeB antibodies in APSGN patients as compared to 
rheumatic fever patients or controls (Cu et al., 1998; Poon-King et al., 1993).  Recent studies 
using a mouse tissue cage model have demonstrated that SpeB expression is inhibited in S. 
pyogenes strains that are maintained in the animal for extended periods, and this inhibition is 
inversely related to the increased expression of phage-encoded pyogenic exotoxins and 
DNases (Aziz et al., 2004).  The strains studied were not associated with nephritis, suggesting 
that group A streptococci which cause APSGN may differentially express this protein when 
compared to non-nephritogenic strains.  The lack of an identifiable homolog to SpeB in the 
group C strain MGCS10565 argues against the necessity of it in either the onset or progression 
of APSGN.  However, the molecular mechanisms that underlie APSGN in the group C species 
may be different in some aspects from group A nephritogenic strains, and thus the absence of 
this protein in MGCS10565 may not be informative about group A APSGN disease.  Further 
studies on this problem are clearly warranted.   
4.3 Surface associated proteins   
4.3.1 The Mga regulon genes 
The molecular mimicry that underlies the onset of rheumatic heart disease results from the 
immune response to a prominent surface antigen of group A streptococci, the M protein.  
Therefore, such immunological cross-reactivity may be expected to contribute to APSGN, 
especially considering the time course of onset of symptoms.  Particular M protein serotypes 
have been associated with APSGN, with M types 2, 49, 42, 56, 57, and 60 being associated 
with skin infections and APSGN while M types 1, 4, 12, and 25 being associated with throat 
infections and APSGN (Bessen et al., 1997; Bessen et al., 1996; Bisno, 1995; Enright et al., 
2001; Kalia et al., 2002; Silva, 1998).  As reported in the original description of the 
MGCS10565 genome, this group C contains a major deletion in much of the Mga regulon, 
including the genes for protease SpeB and the serum opacity factor (sof), although orthologs 
of many of these proteins including the M protein gene (emm) are found elsewhere in this 
genome (Beres et al., 2008).  The genome of MGCS10565 revealed a large number of 
predicted extracellular collagen-like proteins, but none of these provided direct evidence of 
linkage to the nephritis-associated group A streptococcal serotypes.  The linkage of serotype 
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and disease in the streptococcal, while clearly observed, remains somewhat unclear from the 
genetic level in terms of gene linkage or evolutionary co-selection.   
4.3.2 Glyceraldehyde phosphate dehydrogenase (GAPDH) 
Surface associated glyceraldehyde phosphate dehydrogenase (GAPDH) from nephritogenic 
strains of group A streptococci have been implicated in APSGN, with the molecule often 
detected in renal biopsies and patient sera having elevated anti-GAPDH antibody titers 
(Lange et al., 1976; Yamakami et al., 2000; Yoshizawa et al., 1992; Yoshizawa et al., 2004).  
This protein, which also has been referred to in the literature as the nephritis associated 
plasmin receptor, shows >85% homology between S. zooepidemicus MGCS10565 and the 
group A genome strains, which are virtually identical in amino acid sequence (Beres et al., 
2008).  Thus, it seems that if GAPDH plays a role in APSGN it is not a specific trigger for the 
disease.  Indeed, other investigators have failed to find an association between GAPDH and 
APSGN (Batsford et al., 2005), so its role remains somewhat in question.  
4.3.3 Enolase 
Another S. pyogenes surface associated protein that has been implicated in APSGN is 
enolase, which is a major plasminogen binding protein and may be involved in triggering 
APSGN (Fontan et al., 2000).  The phylogenetic analysis of the enolase genes from the S. 
pyogenes, S. zooepidemicus, S. equisimilis subsp. dysgalactiae, S. pneumoniae, and S. mutans 
genomes is presented in Fig. 3.  The two S. zooepidemicus genes form a separate branch that is 
quite distinct from the S. pyogenes genes and encode proteins that are 100% identical.  
 
 
Fig. 3. Phylogenetic analysis of streptococcal enolase genes.  The enolase genes from the 
group A streptococcal genomes (see Fig. 2 legend), now including the non-nephritogenic 
M12 strain MGAS2096, along with the genes from S. zooepidemicus strains MGCS10565 
(nephritogenic) and NC_012470 (non-nephritogenic), S. dysgalactiae subsp. equisimilis 
GGS_124, S. pneumoniae TIGR4, and S. mutans UA159 were compared and a phylogenetic 
tree constructed using Geneious (Drummond et al., 2010).    
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Interestingly, the two nephritogenic group A streptococcal strains, NZ131 and MGAS2096, 
occupy a separate branch from the other S. pyogenes strains.  However, this branch also 
includes the other M12 genome strain (MGAS9429) that was not nephritis associated.  It may 
be that these closely related alleles of enolase play a role in the onset or development of 
APSGN in S. pyogenes, but the presence a non-nephritogenic strain argues that other factors 
must be required.  Further, it would seem that enolase is probably not a common factor 
between groups A and C streptococci in the onset of APSGN. 
4.3.4 Streptococcal pilus genes 
Recent studies have demonstrated that group A streptococci and other Gram positive 
bacteria produce long, pili-like appendages that mediate binding to human fibronectin or 
collagen (Kang et al., 2007; Mora et al., 2005).  These regions are identified by the presence of 
the genes encoding the pilus subunit proteins and their associated C sortases. A 
transcriptional regulator is included in the gene cluster of group A streptococci, and strains 
may be subdivided into two groups based upon whether the pilus region carries rofA or nra 
regulator genes.  A recent classification scheme has described this region in S. pyogenes as 
belonging to one of six FCT groups (Kratovac et al., 2007). Strain NZ131 is a member of the 
nra group (FCT-3) that also includes the M3, M5, and M18 genome strains. 
 
 
Fig. 4. Phylogeny of the streptococcus pili regions.  The phylogenetic tree of the 
streptococcal pilus (fibronectin binding) regions from the S. pyogenes genome strains (see 
Fig. 2 legend) and from MGCS10565 is shown.  The regions from the S. pyogenes genomes 
are indicated by the M protein serotype, and the nephritogenic group A streptococcal strains 
(NZ131 and MGCS2096) and group C strain (MGCS10565) are shaded.  
Group C strain has three potential pilus (fibronectin binding protein) regions (Beres et al., 
2008), which is in contrast to the one pilus (T antigen) cluster found in the group A 
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streptococci (McShan et al., 2008).  Two of the group C pilus regions have homology to the 
pilus regions from the M2 and M6 genomes but little match that genome location in either 
the NZ131 or MGAS2096 chromosomes.  Sortases are Gram-positive transpeptidases that 
anchor pili and other surface proteins to the cell wall (Hae Joo Kang and Baker, 2011; 
Janulczyk and Rasmussen, 2001).  Strain NZ131 encodes an alternate sortase in this region 
(srcC2, Spy49_0116).  Interestingly, the rofA gene in MGCS10565 is not included in this gene 
cluster, being encoded elsewhere on the genome.  When a phylogenetic tree of the pilus 
regions from the S. pyogenes and S. equi subsp. zooepidemicus genomes is constructed (Figure 
4), the three pili regions (FimI – FimIII) form a distinct out-group from the S. pyogenes 
regions.  The regions from the two nephritogenic group A streptococcal strains, NZ131 and 
MGAS2096, also are not closely related to each other, and the diversity of this region again 
argues that this is not the genetic location where are located unique factors that define 
nephritogenic strains of streptococci.  
5. Conclusions   
Comparison of the genomes of nephritogenic strain NZ131 and MGCS10565 reveals many 
similarities and differences that reflect related genera but distinct species.  It is difficult, 
however, to make a convincing argument that an obvious shared trait is responsible for 
APSGN in both strains; rather, it is the differences that seem the most obvious when 
comparing potential virulence mechanisms.   
One striking finding from genome comparison is the level of diversity between the group A 
streptococcal genomes and the genome of MGCS10565.  Indeed, no common link to APSGN 
is immediately evident from the examination of the potential genetic sources from previous 
studies to the genomes.  Beres et al. (Beres et al., 2008), after considering the diversity 
between the group A and group C genomes, tended to discount potential roles for 
streptokinase and protease SpeB in APSGN.  Indeed, these proteins may not be key in the 
onset or progression of the disease although there are a number of studies supporting both.  
However, this conclusion presumes that the mechanism of pathogenesis of APSGN is the 
same in both species, which it well may not be.  Many diarrheal diseases present with 
similar symptoms even though the underlying bacterial infection may be quite different, 
and it is possible that streptococcal nephritis caused by different species may result from a 
different series of molecular events.  Further, even if there is a common molecular trigger for 
APSGN, it may be also true that for some bacterial factors that may amplify or promote the 
disease the phenotype may be more important through their enzymatic activity than their 
antigenicity.  Thus, the important message from genomics at this time is that many aspects 
of APSGN remain to be explored so to uncover the roles played by virulence factors both 
known and yet to be characterized.  Additional genome sequences from nephritogenic 
streptococci would help increase our understanding.  The genomic information that is 
already available provides a rich resource for future studies as well as providing a 
framework for understanding the previous efforts in this field of investigation.  
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